Andrew Bluher

Medicine & Life Sciences

1. Recurrent respiratory papillomatosis 100%
2. Sleep Apnea Syndromes 69%
3. Pediatrics 55%
4. Tympanic Membrane Perforation 46%
5. montelukast 45%
6. Fluticasone 44%
7. Tympanoplasty 44%
8. Obstructive Sleep Apnea 43%
9. Databases 42%
10. Child 41%
11. Sensorineural Hearing Loss 36%
12. Cleft Palate 35%
13. Respiratory Sounds 35%
14. Costs and Cost Analysis 34%
15. Quality of Life 31%
16. Ear 28%
17. Inpatients 25%
18. Obesity 24%
19. Stroke 21%
20. Length of Stay 19%
21. Airway Obstruction 18%
22. Hospital Charges 17%
23. Apnea 14%
24. Transplants 14%
25. Urban Hospitals 14%
26. Laryngoscopes 13%
27. Health Care Costs 11%
28. Hearing Loss 11%
29. Natural History 11%
30. Air 11%
31. Bevacizumab 10%
32. Pediatric Obesity 10%
33. Thinness 9%
34. Bone and Bones 8%
35. Ofloxacin 7%
36. Laryngeal Neoplasms 7%
37. Therapeutics 7%
38. Cleft Lip 7%
39. Vaccination 7%
40. Economic Inflation 7%
41. Laryngopharyngeal Reflux 7%
42. Linear Models 6%
43. Audiovisual Aids 6%
44. Head 6%
45. Calreticulin 6%
46. hydrocortisone, neomycin, polymyxin B drug combination 6%
47. Logistic Models 6%
48. Respiratory Insufficiency 6%
49. Autistic Disorder 5%
50. Otitis Media with Effusion 5%